TransMedics to Report Third Quarter 2026 Financial Results on November 5, 2026
PR Newswire•22/10/2026•16:05 ET
0
Key Highlights
- ➤TransMedics will release third-quarter 2026 financial results November 5 after market close.
- ➤Management will host a conference call at 4:30 p.m. ET on November 5.
- ➤TransMedics (TMDX) develops portable warm perfusion technology for donor organs.
TransMedics to Report Third Quarter 2026 Financial Results on November 5, 2026 PR Newswire
ANDOVER, Mass., Oct. 22, 2026 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure, today announced that it will release financial results for the third quarter 2026 after market close on Thursday, November 5, 2026. The TransMedics management team will host a corresponding conference call beginning at 4:30 p.m. ET / 1:30 p.m. PT.
Get started
Create a free account to read the full story.